Table 2.
Basic clinical and laboratory characteristics of 37 men with metabolic syndrome accomplishing all clinical phases of the study
| Mean (SD) | Range | |
|---|---|---|
| Height, cm | 177.1 (5.7) | 163.0 - 191.0 |
| Weight, kg | 97.4 (16.3) | 68.0 - 142.0 |
| Waist circumference, cm | 111.1 (13.1) | 92.0 - 150.0 |
| BMI, kg/m2 | 31.0 (5.0) | 23.9 - 46.4 |
| SBP, mmHg | 145.5 (12.3) | 122.0 - 172.0 |
| DBP, mmHg | 90.8 (5.6) | 80.0 - 105.0 |
| Fasting glucose, mmol/L | 6.62 (1.19) | 3.3 - 9.5 |
| HbA1C | ||
| (%) | 6.42 (0.66) | 5.3 - 8.7 |
| (mmol/mol) | 46.7 (7.2) | 34.4 - 71.6 |
| Total cholesterol, mmol/L | 5.15 (1.49) | 2.6 - 8.4 |
| HDL-C, mmol/L | 1.15 (0.27) | 0.5 - 1.7 |
| LDL-C, mmol/L | 3.33 (1.25) | 1.1 - 6.0 |
| Triglycerides, mmol/L | 2.19 (1.13) | 0.9 - 6.3 |
| ALAT, U/L | 53.0 (27.4) | 25.0 - 163.0 |
| GT, U/L | 72.4 (62.9) | 15.0 - 275.0 |
| Afos, U/L | 67.6 (19.7) | 30.0 - 115.0 |
| Fibrinogen, g/L | 3.49 (0.96) | 2.3 - 5.5 |